8.580USD-3.98%Mkt Cap: 551.98M USDP/E: —Last update: 2026-06-01
Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company develops proteolysis targeting chimeras (P…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap551.98M USD
Enterprise Value-27.10M USD
Revenue (TTM)89.40M USD
Gross Profit120.20M USD
Net Income (TTM)-80.80M USD
Revenue/Share1.300 USD
Last Price8.580 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees246
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.70
PEG—
EV/EBITDA0.11
EV/Revenue-0.30
P/S6.48
P/B1.50
EPS (TTM)-3.18
EPS (Forward)-3.33
52W Range
6.06030% of range14.51
52W High14.51 USD
52W Low6.060 USD
Profitability
Gross Margin134.45%
Oper. Margin-405.13%
EBITDA Margin-275.73%
Profit Margin-30.77%
ROE-18.63%
ROA-11.26%
Growth
Revenue Growth-91.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-273.80M USD
CapEx (TTM)1.90M USD
FCF Margin-223.31%
FCF Yield-36.17%
Net Debt-606.50M USD
Net Debt/EBITDA2.46
Balance Sheet
Debt/Equity0.02
Current Ratio5.44
Quick Ratio5.36
Book Value/Sh5.997 USD
Cash/Share9.530 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.2 (Buy)
Target (Mean)15.00 USD
Target Range6.000 USD – 24.00 USD
# Analysts16
Ownership
Shares Out.64.52M
Float55.95M
Insiders7.76%
Institutions83.29%
Short Interest
Short Ratio5.7d
Short % Float9.12%
Short % Out.7.81%
Shares Short5.04M
Short (prev mo.)4.39M
Technical
SMA 5010.26 (-16.4%)
SMA 20010.64 (-19.4%)
Beta1.80
S&P 52W Chg27.94%
Avg Vol (30d)824.20K
Avg Vol (10d)861.26K
Technical Indicators
RSI (14)36.5
MACD-0.4619
MACD Signal-0.4649
MACD Hist.+0.0030
BB Upper10.89 USD
BB Middle9.515 USD
BB Lower8.139 USD
BB Width28.92%
ATR (14)0.4842 USD
Vol Ratio (20d)0.50x